VS3 Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

VS3 Medical is an early-stage neurovascular device company targeting the underserved market of symptomatic venous sinus stenosis. Founded in 2022 and backed by premier venture capital firms, the company has advanced its novel stent system into first-in-human clinical studies, with initial cases presented at a major neurointerventional conference in early 2026. The company is led by an experienced team with medical device and neurovascular expertise and is currently in a pivotal clinical development phase with its sole, focused program.

NeurovascularOtology/Neurology

Technology Platform

A dedicated neurovascular stent system engineered specifically for the low-pressure, compliant, and complex anatomy of the dural venous sinuses, designed to treat symptomatic venous sinus stenosis.

Opportunities

VS3 Medical addresses a large, underserved patient population with symptomatic venous sinus stenosis, where current treatments are limited to off-label use of non-specialized stents.

Successful development could establish a new standard of care in neurointervention.

Rising diagnosis rates due to better imaging and awareness expand the treatable market.

Risk Factors

The company faces significant clinical trial risk, as failure to demonstrate safety and efficacy would be catastrophic.

Regulatory approval for a novel Class III device is uncertain and lengthy.

Future commercial success depends on physician adoption and securing favorable insurance reimbursement in a cost-conscious environment.

Competitive Landscape

Direct competition is currently limited, as there are no FDA-approved stents specifically for venous sinus stenosis. The main competition is the off-label use of stents designed for coronary, biliary, or peripheral arteries. Other neurovascular or venous device companies could enter the space if VS3 demonstrates clinical and commercial validation.

More companies in Diagnostics & Precision Medicine →More companies in United States →